Lanean...
Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders
A new approach is adopted to treat primary immunodeficiency disorders, such as the severe combined immunodeficiency (SCID; e.g., adenosine deaminase SCID [ADA-SCID] and IL-2 receptor X-linked severe combined immunodeficiency [SCID-X1]). The success, along with the feasibility of gene therapy, is und...
Gorde:
| Argitaratua izan da: | Open Life Sci |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
De Gruyter
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8093481/ https://ncbi.nlm.nih.gov/pubmed/33987480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/biol-2021-0033 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|